Related Experiment Video
Updated: May 17, 2026

07:51
Development and Functionalization of Electrolyte-Gated Graphene Field-Effect Transistor for Biomarker Detection
Published on: February 1, 2022
Vertical graphene-based electrochemical sensor for cisplatin detection and molecular recognition
Bianca Adiaconita1, Eugen Chiriac1, Catalin Marculescu1
1National Institute for Research and Development in Microtechnologies - IMT Bucharest, 126A, Erou Iancu Nicolae Street, Voluntari, 077190, Romania.
Talanta
|May 15, 2026
Summary
This study introduces a novel dual-architecture electrochemical platform using vertical graphene for sensitive, label-free detection of cisplatin. The device simultaneously monitors drug levels and probes its interactions with nucleic acids for improved cancer therapy.
Area of Science:
- Electrochemistry
- Materials Science
- Analytical Chemistry
Background:
- Platinum-based chemotherapeutics like cisplatin are vital but challenging to monitor due to their narrow therapeutic index and reactivity.
- Accurate monitoring is crucial for optimizing efficacy and minimizing toxicity.
- Existing analytical methods face limitations in sensitivity, specificity, or real-time interaction analysis.
Purpose of the Study:
- To develop a dual-architecture electrochemical platform for label-free cisplatin detection.
- To enable biomimetic probing of cisplatin's molecular interactions with nucleic acids.
- To provide a versatile tool for therapeutic drug monitoring and understanding platinum-DNA interactions.
Main Methods:
- Fabrication of a dual-architecture platform on vertical graphene (VG) interdigitated electrodes (IDEs).
- Integration of two sensing interfaces: VG decorated with gold nanoparticles (VG/AuNPs) for electrocatalysis and VG functionalized with guanine probes (VG/PolyG) for molecular recognition.
- Characterization using FTIR, Raman, SEM, EDX, and electrochemical techniques (CV, DPV, EIS).
Main Results:
- The VG/AuNPs sensor demonstrated a linear response to cisplatin (0.5-10 μM, R²=0.9595) with a LOD of 3.29 μM.
- The VG/PolyG interface successfully transduced Pt-N7 guanine coordination into measurable changes in charge-transfer resistance.
- Surface characterization confirmed successful functionalization and nanoparticle decoration.
Conclusions:
- The developed dual-architecture platform effectively combines electrocatalytic amplification with biomimetic molecular recognition.
- This integrated device offers a sensitive and mechanistically informative approach for cisplatin monitoring and studying drug-nucleic acid interactions.
- The platform holds promise for advancing personalized cancer therapy and fundamental research in platinum-based drugs.
